Genetic features of clinical Pseudomonas aeruginosa strains

• Autorzy: Wolska K , Szweda P.
• Języki publikacji: EN

Abstrakty

EN

The genetic features of each isolate were determined by enterobacterial repetitive intergenic consensus (ERIC) primer sequences used in PCR and by searching for six virulence genes (alg D, las B, tox A, plc H,plc N, exo S). 49 (79%) of the isolates were distributed in three ERIC PCR subgroups and showed 62% of similarity. The remaining 13 strains generated unique patterns. The first subgroup was primarily composed of isolates from faeces, these strains indicated over 70% relationship with the next subgroup, and primarily contained strains isolated from wounds and bronchial washings and the last subgroup contained strains isolated from wounds and urine. The unique strains were isolated mainly from urine. Statistical analysis indicated that variations in distribution of virulence genes in P. aeruginosa isolates with respect to strain origin and genomic subgroups were not significant. In the group of 49 strains, 100% gave a positive reaction to alg D, las B and plc H genes, 91.8% to tox A and plc N genes and 83.7% to exo S gene. Among the strains that generated unique (ERIC-PCR) patterns, 69.2% gave a positive reaction to alg D gene, 84.6% to las B gene, 76.9% to tox A, plc N and plc H genes, and 46.15% to exo S gene.

Słowa kluczowe

EN

polymerase chain reaction; isolation; pathogen; clinical strain; Pseudomonas aeruginosa; human infection; virulence gene; enterobacterial repetitive intergenic consensus; hospital; genetic feature

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2009
• Tom: 58
• Numer: 3
• Opis fizyczny: p.255-260,fig.,ref.

Twórcy

autor

Wolska K

• University of Podlasie in Siedlce, Prusa 12, 08-110 Siedlce, Poland

autor

Szweda P.

Bibliografia

• Bennekov T., H. Colding, B. Ojeniyi, M.W. Bentzon and N. Hoiby. 1996. Comparison of ribotyping of Pseudomonas aeruginosa isolates from cystic fibrosis patients. J. Clin. Microbiol. 34: 202-204.
• Carratala J., B. Roson, A. Fernandez-Sevilla, F. Alcaide and F. Gudiol. 1998. Bacteremic pneumonia in neutropenic patients with cancer. Arch. Intern. Med. 158: 868-872.
• Cheng K.H., S.L. Leung, H.W. Hoekman, W.H. Beekhuis, P.G. Mulder, A.J. Geerards and A. Kijlstra. 1999. Incidence of contact-lens-associated microbial keratitis and its related morbidity. Lancet 354: 181-185.
• Endimiani A., B. Pini, A. Baj, F. Luzzaro and A. Toniolo. 2006. Bloodstream infections due to Pseudomonas aeruginosa: clinical outcome associated with pathogenesis-related genes. Abstracts 16th European Congress Clinical Microbiology and Infectious Disease 2006. Nice, France p. 1164.
• Feltman H., G. Schlert, S. Khan, M. Jain, L. Peterson and A.R. Hauser. 2001. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 147: 2659-2669.
• Ferguson M.W., J.A. Maxwell, T.S. Vincent, J. da Silva and J.C. Olson. 2001. Comparison of the exo S gene and protein expression in soil and clinical isolates oí Pseudomonas aeruginosa. Infect. Immun. 69: 2198-2210.
• Goldsworthy M.J.H. 2008. Gene expression of Pseudomonas aeruginosa and MRSA within a catheter-associated urinary tract infection biofilm model. Bioscience Horizons 1: 28-37.
• Govan J.R. and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60: 539-574.
• Hamood A.N., J.A. Griswold and C.M. Duhan. 1996. Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract and wound infections. J. Surg. Research 61: 425-432.
• Hancock R.E. and D.P. Speert. 2000. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment. Drug. Resist. Updat. 4: 247-255.
• Joly B., M. Pierre, S. Auvin, F. Colin, F.B. Guery and M.O. Husson. 2005. Relative expression of Pseudomonas aeruginosa virulence genes analyzed by a real time RT-PCR method during lung infection in rats. FEMS Microbiol. Lett. 243: 271-278.
• Lanotte P., S. Watt, L. Mereghetti, N. Dartiguclongue, A. Raster-Lari, A. Goudeau and R. Quentin. 2004. Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins. J. Med. Microbiol. 53: 73-81.
• Lin H., S. Huang, H. Teng, D. Ji, Y. Chen and Y. Chen. 2006. Presence of the exo U gene of Pseudomonas aeruginosa is correlated with cytotoxicity in MDCK cells but not with colonization in BALB/c mice. J. Clin. Microbiol. 44: 4596-4597.
• Mecalanos J.J. 1992. Environmental signals controlling expression of virulence determinants in bacteria. J. Bacteriol. 174: 1-7.
• Ostroff R.M., A.I. Vasil and M.L. Vasil. 1990. Molecular comparison of nonhemolytic and a hemolytic phospholipase C from Pseudomonas aeruginosa. J. Bacterial. 172: 5915-5923.
• Rietsch A., I. Vallet-Gely, S.L. Dove and J.J. Mekalanos. 2005. ExsE, a secreted regulator of type III secretion genes in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. 102: 9006-8011.
• Rumbaugh K.P., B.S. Abdul, N. Hamood and J.A. Griswold. 1999. Analysis of Pseudomonas aeruginosa clinical isolates for possible variations within the virulence genes exotoxin A and exoenzyme S.J. Surg. Research 82: 95-105.
• Rumbaugh K.P., J.A. Griswold and A.N. Hamood. 1999. Pseudomonas aeruginosa strains obtained from patients with tracheal, urinary tract and wound infection: variations in virulence factors and virulence genes. J. Hosp. Infect. 43: 211-218.
• Speert D.P. 2002. Molecular epidemiology of Pseudomonas aeruginosa. Front. Biosci. 7: e354-e361.
• Storey D.G., E.E. Ujack, J. Mitchell and H.R. Rabin. 1997. Positive correlation of algD transcription to las B and las A transcription by populations of Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. Infect. Immun. 65: 4061-4067.
• Stover C.K., X.Q. Pham, A.L. Erwin, S.D. Mizoguchi, P. Warrener, M.J. Hickey, F.S.L. Brinkman, W.O. Hufnagle and D.J. Kowalik. 2000. Complete genome sequence of Pseudomonas aeniginosa PAO1, an opportunistic pathogen. Nature 406: 959-964.
• Toder D.S., S.J. Ferrell, J.L. Nezezon, L. Rust and B.H. Iglewski. 1994. Las A and las B genes of Pseudomonas aeruginosa : Analysis transcription and gene product activity. Infect. Immun. 62: 1320-1327.
• Van Delden C. and B.H. Iglewski 1998. Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emeig. Infect. Dis. 4: 551-60. Versalovic J., T. Koeuth and J.R. Lupski. 1991. Distribution of repetive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleid Acids Res. 19: 6823-6831.
• Wolska K. and P. Szweda. 2008. A comparative evaluation of PCR ribotyping and ERIC PCR for determining the diversity of clinical Pseudomonas aeruginosa isolates. Pol. J. Microbiol. 57: 157-163.
• Yahr T.L., A.K. Hovey, S.M. Kulich and D.W. Frank. 1995. Transcriptional analysis of the Pseudomonas aeruginosa exoenzyme S structural gene. J. Bacteriol. 177: 1169-1178.
• Zaborina O., J.E. Kohler, Y. Wang, C. Bethel, O. Shevchenko, L. Wu, J.R. Turner and J.C. Alverdy. 2006. Identification of multi-drug resistant Pseudomonas aeruginosa clinical isolates that highly disruptive to the intestinal epithelial barrier. An. Clin. Microbiol. Antimicrob. 5: 1-14.